Dex Pharma R3ta Max 50mg/3mL Research Pen

R 2,900.00 R 2,700.00

Dex Pharma R3ta Max Research Peptide — 50mg / 3ml

Dex Pharma R3ta Max is a research-focused peptide product containing 50mg of R3t@trutide in a 3ml pre-filled research format, intended for laboratory and scientific research.

Product Overview

R3t@trutide is an investigational synthetic peptide that has attracted significant scientific interest because of its activity across three receptor pathways: GLP-1, GIP and glucagon.

Research into R3t@trutide has explored metabolic signalling, glucose regulation, energy metabolism, body-weight outcomes and related cardiometabolic research areas.

Key Features

  • 50mg R3t@trutide
  • 3ml pre-filled research format
  • Triple-receptor research target: GLP-1, GIP and glucagon
  • Research-focused product specification
  • Suitable for laboratory and scientific research applications
  • Manufactured and presented for research purposes

Research Focus

R3t@trutide (LY3437943) is being investigated for its potential effects across multiple metabolic pathways. Its combined receptor activity makes it an area of ongoing interest in obesity, metabolic and cardiometabolic research.

This product is supplied for research purposes only. It is not presented as an approved treatment or as a recommendation for human use.

Key Features


50mg R3t@trutide research peptide; 3mL pre-filled research pen format; triple-receptor research focus involving GLP-1, GIP and glucagon pathways; research-focused product specification; intended for laboratory and scientific research.

Dosage & Usage


Research Reference & Study Protocol Notes: Published R3t@trutide research may include different experimental models, concentrations and study designs. Researchers should consult the relevant primary literature and establish protocols appropriate to their specific research model. This product information is provided for laboratory research reference only.

FAQ's & Tips


Frequently Asked Questions — Dex Pharma R3t@ Max 50mg/3mL Pen. What is R3t@trutide? R3t@trutide is an investigational peptide studied for activity across GLP-1, GIP and glucagon receptors. What is the Dex Pharma R3t@ Max? It is a 50mg/3mL pre-filled research peptide pen format. What is it researched for? Research has investigated metabolic signalling, energy balance and body-weight-related outcomes. Is R3t@trutide approved as a medicine? No. R3t@trutide remains an investigational compound and should not be presented as an approved treatment. Who is this product for? It is supplied for qualified laboratory and scientific research.

Research


Research Reference & Study Information: R3t@trutide is an investigational triple-receptor agonist studied for activity involving GLP-1, GIP and glucagon pathways. Research has explored metabolic regulation, energy balance and body-weight-related outcomes. For laboratory research reference only.

Reviews